OR WAIT null SECS
Click here to read the articles and download the PDF
Pharma’s prime chance to reduce carbon emissions from supply chain
Three keys to achieving digital excellence in the next normal, where a hybrid commercial model will be the standard for physician engagement
The steps pharma manufacturers can take to mitigate transportation costs amid Covid’s supply-chain crunch
October 25, 2021
Deal provides ten23 with drug product development, biologic manufacturing experience
October 21, 2021
Agreement prioritizes ways to better distinguish biological manufacturing processes
October 20, 2021
As life sciences companies pursue interoperability across their organizations, medical information and local pharmacovigilance are two operational areas that can deliver benefits, while enabling broader collaboration and digital transformation
Italian facilities will supply EU with up to 85 million doses of Covid jab
October 19, 2021
Biologics manufacturer to construct new C> facility to support expansion
October 18, 2021
Facility meets cGMP standards for radiopharmaceutical production
CDTMO’s fourth site further expands its support of cell therapy delivery and access
October 15, 2021
Delivering critical insights and relevant messaging at precise moments of the patient journey
Second NJ location will complement global HQ, offer plasmid DNA and AAV production services
October 14, 2021
Exploring new guidances and future challenges for pharma trading partners in meeting looming DSCSA mandates in the US
